Beta Drugs IPO Details

IPO Open Sep 29, 2017
IPO Close Oct 4, 2017
IPO Price ₹85
Face Value ₹10
IPO Size ₹19.52 Cr
Listing At NSE SME
Lot Size 1600
Open an Instant Account with Zerodha
  1. Beta Drugs Chairman Speech

    Aug 14, 2020 8:33:00 AM

    Further, it gives me immense pleasure to present the 13th Annual Report of Beta Drugs Limited. I am glad to share our first post IPO annual report. FY 2017-2018 was a momentous year in the company''s ...

    Publish by : Indiatimes
  2. Beta-Lactam Drugs Market

    Dec 6, 2017 4:07:00 AM

    Beta-lactams are antibacterial drugs that possess the basic characteristic of inhibition of bacterial cell wall synthesis. All Beta-lactams possess similar chemistry, with the exception of alkyl ...

    Publish by : Transparency Market Research
  3. Beta Drugs Half Yearly results

    Nov 27, 2022 3:30:00 AM

    The Half Yearly Results page of Beta Drugs Ltd. presents the key Half Yearly result items, its comparison with the sector peers and its previous 5 Half Yearly Results.

    Publish by : Indiatimes
  4. Roche shutters most trials of Alzheimers drug after failed trials

    Dec 1, 2022 3:48:00 AM

    CHICAGO (Reuters) - Swiss drugmaker Roche is closing down most clinical trials of its experimental Alzheimer's drug gantenerumab after it failed to slow advance of the mind-robbing disease in a pair ...

    Publish by : Yahoo News Canada
  5. Alibaba Underwriters Go From Alpha to Beta in IPO

    Nov 25, 2022 3:30:00 AM

    In Facebook's case, Morgan Stanley got the coveted lead left status and ran the company's $16 billion IPO. Goldman Sachs won that mandate in Twitter's IPO. In the lead up to both of those ...

    Publish by :
  6. Drug Developer Phenomix Nixes $86.25M IPO

    Oct 23, 2022 4:30:00 AM

    For Phenomix, $34 million of the IPO proceeds would have funded the firm’s late-stage studies of its lead drug (PHX1149) for Type 2 diabetes, according to an SEC filing. In May, the company ...

    Publish by : Xconomy
  7. IPO Calendar

    Nov 23, 2022 2:10:00 PM

    An initial public offering (IPO) is a company’s 1st entry into the public stock market. Sometimes referred to as “going public,” a company’s IPO allows it to raise capital by offering ...

    Publish by :
  8. Nasdaqs IPO Process

    Aug 13, 2020 10:40:00 AM

    We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Despite the uncertainty ...

    Publish by : Nasdaq
  9. Centrexion Plans IPO to Bankroll Non-Opioid Pain Drugs

    Oct 22, 2022 4:30:00 AM

    Should Centrexion close its IPO, it will list on the Nasdaq under the symbol CNTX. Centrexion, headed by former Pfizer CEO Jeff Kindler, is testing its lead drug, CNTX-4975, in two Phase 3 ...

    Publish by : Xconomy
  10. Table of Contents

    Oct 25, 2022 9:54:00 AM

    Investopedia / Zoe Hansen An initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time. An IPO allows ...

    Publish by : Investopedia
  11. Can a Starlink IPO Succeed?

    Nov 26, 2022 4:13:00 PM

    when SpaceX announced introductory "beta" pricing for Starlink internet service. Interest in a Starlink IPO probably peaked last year, after Elon Musk tweeted support for his COO's prediction ...

    Publish by : Nasdaq

Beta Drugs IPO Alerts

1. Beta Drugs Limited IPO - Close  Wednesday, September 27, 2017 10:39:31 AM

The issue of Beta Drugs Limited opens on Sep 29, 2017 and closes for subscription on Oct 04, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 85.

2. Beta Drugs Limited IPO - Open  Wednesday, September 27, 2017 10:39:12 AM

Beta Drugs Limited is entering in the capital market with an IPO of 229,600 Equity Shares of Rs 10 aggregating up to Rs 1.95 Cr. The price band for the issue has been fixed at Rs 85.

Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.

The issue opens on Sep 29, 2017 and closes for subscription on Oct 4, 2017. The equity shares of the company to be list at NSE SME platform.

Beta Drugs IPO News & Events FAQs

The Beta Drugs IPO is proposed to open on Sep 29, 2017. The IPO application ends on Oct 4, 2017.

Retail investors can apply in the retail or non-institutional investor category from Sep 29, 2017 to Oct 4, 2017. The Beta Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Beta Drugs IPO will open for subscription on Sep 29, 2017. The public issue will close on Oct 4, 2017.